[email protected] +91 9789129171
ICHTA · Registering as Listener

International Conference on HIV Treatment and Antiretroviral Therapy

3 - 4 Mar 2027 Winnipeg, Canada Standard / Physical Participation
Listener Registration
$115
virtual · $175 in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.


Coupon code

Have a code? Apply it here — the discount updates the total immediately.


Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceICHTA
ModeStandard / Physical
ParticipationListener
Registration fee$175.00
Bank charges (5.8%)$10.15
Total payable$185.15
Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

+91 9789129171

Benefits of Registering as Listener

Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
• Conference Session Tracks •
SDGs
SDG-Aligned Research Themes

ICHTA conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 - Good Health and Well-being SDG 4 - Quality Education SDG 9 - Industry, Innovation and Infrastructure SDG 10 - Reduced Inequalities
01 Advancements in Antiretroviral Therapy +
This track will explore the latest developments in antiretroviral therapies, focusing on novel drug formulations and mechanisms of action. Discussions will include the implications of these advancements for treatment efficacy and patient outcomes.
02 Clinical Management of HIV: Best Practices +
This session will address the clinical management of HIV, emphasizing evidence-based practices and guidelines. Participants will examine case studies that highlight successful management strategies and patient care models.
03 Patient Adherence to HIV Treatment +
This track will investigate factors influencing patient adherence to HIV treatment regimens, including psychological, social, and economic determinants. Strategies to enhance adherence and improve health outcomes will also be discussed.
04 Pharmacology of HIV Medications +
This session will delve into the pharmacological aspects of HIV medications, including drug interactions and side effects. Emphasis will be placed on optimizing therapeutic regimens for diverse patient populations.
05 Innovations in HIV Therapeutics +
This track will showcase cutting-edge therapeutic innovations in the field of HIV treatment, including long-acting formulations and novel delivery systems. The potential impact of these innovations on patient care will be critically assessed.
06 Clinical Trials in HIV Research +
This session will provide an overview of ongoing and completed clinical trials in HIV treatment, highlighting key findings and implications for practice. Participants will engage in discussions about the future directions of HIV research.
07 Molecular Diagnostics in HIV Management +
This track will focus on the role of molecular diagnostics in the management of HIV, including viral load monitoring and resistance testing. Participants will explore how these technologies can inform treatment decisions and improve patient outcomes.
08 Laboratory Techniques in HIV Research +
This session will cover advanced laboratory techniques used in HIV research, including novel assays and bioinformatics approaches. The importance of these techniques in understanding HIV pathogenesis and treatment response will be emphasized.
09 Translational Research in HIV Treatment +
This track will highlight the importance of translational research in bridging the gap between laboratory discoveries and clinical applications in HIV treatment. Case studies will illustrate successful translation of research findings into practice.
10 Global Perspectives on HIV Treatment +
This session will examine global disparities in HIV treatment access and outcomes, with a focus on low- and middle-income countries. Participants will discuss strategies to address these challenges and improve global health equity.
11 Psychosocial Aspects of HIV Care +
This track will explore the psychosocial factors affecting individuals living with HIV, including stigma, mental health, and social support. Strategies to integrate psychosocial care into HIV treatment will be discussed to enhance overall patient well-being.